found: Genome engineering via CRISPR-Cas9 system, 2020:title page (Vijai Singh, editor) page xv (Dr. Vijai Singh is an Associate Professor in the Department of Biosciences, School of Science at Indrashil University, Mehsana, Gujarat, India. Prior to this, Dr. Singh was a postdoctoral fellow at Institute of Systems and Synthetic Biology, France and School of Energy and Chemical Engineering at Ulsan National Institute of Science and Technology, South Korea. Dr. Singh has served as an Assistant Professor in the Department of Biotechnology at Invertis University, India and Department of Biological Sciences and Biotechnology, Institute of Advanced Research, India. Dr. Singh received his Ph.D. in Biotechnology from Dr. A.P.J. Abdul Kalam Technical University/National Bureau of Fish Genetic Resources, Lucknow, India with a research focus on the development of molecular and immunoassay for Aeromonas hydrophila. Dr. Singh has designed and characterized a number of synthetic oscillators, gene networks, lycopene pathway, MAGE and CRISPR-Cas9 system in Escherichia coli. Currently, Dr. Singh's laboratory focuses on the construction of a novel biosynthetic pathway for the production of pigments, chemicals, and fuels. Additionally, Dr. Singh's laboratory works on developing CRISPR-based platform for disease diagnosis and eradication of MDR pathogens. Dr. Singh has published 72 articles, 19 chapters, and 1 book. Dr. Singh serves as a member of the editorial board and reviewer of a number of peer-reviewed journals.)